How to manage Waldenstrom's macroglobulinemia

por Buske, C, Leblond, V
Publicado 2013

Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission: Results and prognostic factors in 326 consecutive patients

por Belkacémi, Y., Pène, F., Touboul, E., Rio, B., Leblond, V., Gorin, N. C., Laugier, A., Gemici, C., Housset, M., Ozsahin, M.
Publicado 1998

Waldenström's macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders

por Perrot, A, Pionneau, C, Azar, N, Baillou, C, Lemoine, F M, Leblond, V, Merle-Béral, H, Béné, M-C, Herbrecht, R, Bahram, S, Vallat, L
Publicado 2012

Report of consensus panel 5 from the 11th international workshop on Waldenstrom's macroglobulinemia on COVID-19 prophylaxis and management

por Terpos, E., Branagan, A.R., García-Sanz, R., Trotman, J., Greenberger, L.M., Stephens, D.M., Morel, P., Kimby, E., Frustaci, A.M., Hatjiharissi, E., San-Miguel, J., Dimopoulos, M.A., Treon, S.P., Leblond, V.
Publicado 2023

P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM)

por Dimopoulos, M., Opat, S., D’Sa, S., Jurczak, W., Lee, H.-P., Cull, G., Owen, R. G., Marlton, P., Wahlin, B. E., Garcia-Sanz, R., McCarthy, H., Mulligan, S., Tedeschi, A., Castillo, J. J., Czyz, J., Fernandez De Larrea Rodriguez, C., Belada, D., Libby, E., Matous, J., Motta, M., Siddiqi, T., Tani, M., Trneny, M., Minnema, M., Buske, C., Leblond, V., Treon, S. P., Trotman, J., Chan, W. Y., Schneider, J., Allewelt, H., Cohen, A., Huang, J., Tam, C. S.
Publicado 2022